Trends on SGX Nifty indicate a positive opening for India, with a 68 points, or 0.56 percent, gain
Dinesh Rohira, CEO and Founder of 5nance.com has taken a contra view on Alembic Pharmaceuticals.
Trends on SGX Nifty indicate a flat opening for the broader index in India, with a seven-point loss, or 0.06 percent
TCS | Wipro | RBL Bank | IRB Infrastructure | Sun Pharma Advanced Research | Oil India | TVS Motor | Tata Communications | Nestle India | Reliance Infrastructure | MT Educare | United Breweries | JM Financial | Shriram City Union Finance | Inox Leisure and Marico are stocks, which are in the news today.
Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today -- BHEL, M&M, Rallis, Biocon, Indiabulls Housing Finance, Marksans Pharma, MCX, Alembic Pharma, Delta Corp, and Pincon Spirits.
The US drug regulator had inspected its Baroda unit between March 6 and 10 and issued no Form 483s for the same.
Jigar Shah of Kim Eng Securities is of the view that one may see further upmove in Alembic Pharmaceuticals.
Cymbalta, which is used to treat depression and anxiety disorders, lost patent protection on December 12.
Dharmesh Kant of Indianivesh Securities recommends buying Alembic Pharmaceuticals with a target of Rs 220 and Arvind with a target of Rs 136.
Pankaj Jain of Sunteck Wealthmax recommends buying GMR Infrastructure with a target of Rs 24.95 and Peninsula Land with a target of Rs 43.45.
Krish Subramanium of Asit C Mehta advises buying Mangalore Refinery and Petrochemicals for a target price of Rs 45.75 and Torrent Pharma for a target price of Rs 512.
Dharmesh Kant of India Nivesh Securities advises buying Bajaj Finance with a target price of Rs 1,320 and JB Chemicals with a target price of Rs 99.
Saurabh Mittal of Swadeshi Credits recommends buying Motherson Sumi with a target price of Rs 237 and Canara Bank with a target price of Rs 232.
Prakash Diwan of Altamount Capital Management recommended buying Hindustan Zinc with a target price of Rs 129.90 and Alembic Pharma with a target price of Rs 145.50.
In an interview to CNBC-TV18, Amin adds that the company, despite the drug pricing policy, will grow at 15 percent.
Shahina Mukadam of Varun Capital recommends buying Chambal Fertilisers and Chemicals with a target of Rs 40 and advises to sell Hindustan Petroleum Corporation with a target of Rs 227.
Sharmila Joshi of Peerless Securities advised buying Alembic Pharma with a target price of Rs 168 and Escorts with a target price of Rs 80.
Rajesh Agarwal of Eastern Financiers advised buying Mahindra Ugine for a target price of Rs 93 and IVRCL for a price target of Rs 17.50.
Ranbaxy shares declined a further 2 percent on Wednesday morning after a media report said a prominent hospital in Mumbai had advised doctors to stop using the pharma company's drugs.
Alembic Pharma is hopeful to increase operating margin by 100-120 basis points in current financial year on the back of strong growth in international and domestic generic business.
SP Tulsian, sptulsian.com advises traders to avoid Alembic Pharma at current levels.
Alembic Pharmaceuticals expects 100 basis points improvement in its EBITDA as it has earned exclusive rights to sell Pristiq generic tablets for 24 Months.
SP Tulsian of sptulsian.com advised buying Alembic Pharma at around Rs 82-84. He expects the stock to hit these levels in a week.
Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.
Alembic Pharma has target of Rs 100, says SP Tulsian, sptulsian.com